awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49963693-D21C3C0B-3459-457D-85EB-169D8A4C02BE
Q49963693-D21C3C0B-3459-457D-85EB-169D8A4C02BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49963693-D21C3C0B-3459-457D-85EB-169D8A4C02BE
Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes.
P2860
Q49963693-D21C3C0B-3459-457D-85EB-169D8A4C02BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49963693-D21C3C0B-3459-457D-85EB-169D8A4C02BE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c6c31ceed23d05f4b18effe3e79cc01e615150f2
P2860
Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study